Viatris (VTRS) Treasury Shares (2019 - 2026)
Viatris (VTRS) posted Treasury Shares of $1.2 billion for Q2 2026, up 14.89% on a QoQ basis from $1.0 billion in Q1 2026, and up 35.21% year-over-year from $855.8 million in Q2 2025.
Analysis
Viatris (VTRS) Treasury Shares (2019 - 2026) Analysis & Trends
Viatris has reported Treasury Shares for 2 years, with the latest figure at $24.6 million in Q1 2020.
- On a quarterly basis, Treasury Shares rose 35.21% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 35.21% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 99.72% from the prior year.
- Treasury Shares was $1.2 billion for Q2 2026 at Viatris, up from $1.0 billion in the prior quarter.
- The five-year high for Treasury Shares was $1.2 billion in Q2 2026, with the low at $251.8 million in Q1 2023.
- Average Treasury Shares over 4 years is $618.3 million, with a median of $504.3 million recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares jumped 100.28% in 2024, then jumped 34.8% in 2025.
- Over 4 years, Treasury Shares stood at $251.8 million in 2023, then surged by 100.28% to $504.3 million in 2024, then soared by 99.72% to $1.0 billion in 2025, then increased by 14.88% to $1.2 billion in 2026.
- The last three Treasury Shares figures came in at $1.2 billion (Q2 2026), $1.0 billion (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 106.00 Mn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 1.16 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -16.50 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 891,915.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -19.77 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Bn |
| Jun 30, 2026 | 1.16 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Dec 31, 2025 | 1.01 Bn |
| Sep 30, 2025 | 924.20 Mn |
| Sep 30, 2025 | 924.20 Mn |
| Jun 30, 2025 | 855.80 Mn |
| Jun 30, 2025 | 855.80 Mn |
| Mar 31, 2025 | 679.80 Mn |
| Mar 31, 2025 | 679.80 Mn |
| Dec 31, 2024 | 504.30 Mn |
| Dec 31, 2024 | 504.30 Mn |
| Sep 30, 2024 | 504.30 Mn |
| Sep 30, 2024 | 504.30 Mn |
| Jun 30, 2024 | 504.30 Mn |
| Jun 30, 2024 | 504.30 Mn |
| Mar 31, 2024 | 504.30 Mn |
| Mar 31, 2024 | 504.30 Mn |